Wockhardt zooms on partnering with RDIF

13 Aug 2021 Evaluate

Wockhardt is currently trading at Rs. 513.25, up by 23.95 points or 4.89% from its previous closing of Rs. 489.30 on the BSE.

The scrip opened at Rs. 497.45 and has touched a high and low of Rs. 527.00 and Rs. 494.25 respectively. So far 144406 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 804.50 on 26-May-2021 and a 52 week low of Rs. 266.00 on 24-Sep-2020.

Last one week high and low of the scrip stood at Rs. 527.00 and Rs. 470.70 respectively. The current market cap of the company is Rs. 5686.95 crore.

The promoters holding in the company stood at 69.68%, while Institutions and Non-Institutions held 2.82% and 27.49% respectively.

Wockhardt and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19. The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1477.30 16.15 (1.11%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.